Rockwell Medical, Inc.
RMTI
$0.69
$0.033.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 67.68M | 69.26M | 75.58M | 87.97M | 97.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.68M | 69.26M | 75.58M | 87.97M | 97.73M |
| Cost of Revenue | 56.13M | 57.56M | 64.13M | 72.55M | 80.27M |
| Gross Profit | 11.55M | 11.70M | 11.45M | 15.42M | 17.46M |
| SG&A Expenses | 16.36M | 16.39M | 16.26M | 16.71M | 16.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.49M | 73.95M | 80.39M | 89.26M | 97.16M |
| Operating Income | -4.81M | -4.69M | -4.81M | -1.29M | 572.00K |
| Income Before Tax | -5.40M | -5.31M | -5.52M | -2.10M | -264.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.40 | -5.31 | -5.52 | -2.10 | -0.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.40M | -5.31M | -5.52M | -2.10M | -264.00K |
| EBIT | -4.81M | -4.69M | -4.81M | -1.29M | 572.00K |
| EBITDA | -2.65M | -2.50M | -2.62M | 896.00K | 2.75M |
| EPS Basic | -0.15 | -0.16 | -0.17 | -0.08 | -0.02 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.10 | -0.04 | 0.00 |
| EPS Diluted | -0.16 | -0.16 | -0.18 | -0.09 | -0.03 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.10 | -0.04 | -0.01 |
| Average Basic Shares Outstanding | 149.16M | 143.85M | 137.32M | 132.85M | 128.99M |
| Average Diluted Shares Outstanding | 149.16M | 143.85M | 137.32M | 133.72M | 131.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |